AMENDMENT NO. 1 TO sETTLEMENT AND INVESTMENT AGREEMENTSettlement and Investment Agreement • April 30th, 2024 • GT Biopharma, Inc. • Pharmaceutical preparations • Delaware
This Amendment No. 1 to Settlement and Investment Agreement (this “Amendment”) is entered into as of April 25, 2024 (the “Effective Date”), by and between GT Biopharma, Inc., a Delaware corporation (“GTBP”), and Cytovance Biologics, Inc., a Delaware Corporation (“Cytovance”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to such terms in the Original Agreement (as defined below).
